Gabelli Funds LLC Organon & Co. Transaction History

Gabelli Funds LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $498,645 - $612,675	-15,750 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$30.45 - $39.36 $479,587 - $619,920	15,750 New	15,750 $550,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $784,087 - $1.01 Million	-25,750 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $26,519 - $34,345	-925 Reduced 3.47%	25,750 $784,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $274,876 - $342,179	-9,601 Reduced 26.47%	26,675 $875,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $1.03 Million - $1.38 Million	36,276 New	36,276 $1.1 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.